TCP
ALXN
Tourbillon Capital Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-353,106
| Closed | -$43.8M | – | 61 |
|
|
2018
Q2 | $43.8M | Sell |
353,106
-4,710
| -1% | -$585K | 1.7% | 9 |
|
|
2018
Q1 | $39.9M | Sell |
357,816
-241,157
| -40% | -$26.9M | 1.58% | 19 |
|
|
2017
Q4 | $71.6M | Sell |
598,973
-976,056
| -62% | -$117M | 2.65% | 5 |
|
|
2017
Q3 | $221M | Sell |
1,575,029
-73,923
| -4% | -$10.4M | 5.35% | 2 |
|
|
2017
Q2 | $201M | Buy |
1,648,952
+756,131
| +85% | +$92M | 3.86% | 4 |
|
|
2017
Q1 | $108M | Buy |
892,821
+159,161
| +22% | +$19.3M | 2.79% | 8 |
|
|
2016
Q4 | $89.8M | Buy |
733,660
+146,056
| +25% | +$17.9M | 1.73% | 10 |
|
|
2016
Q3 | $72M | Buy |
587,604
+17,500
| +3% | +$2.14M | 1.47% | 16 |
|
|
2016
Q2 | $66.6M | Buy |
+570,104
| New | +$66.6M | 1.33% | 14 |
|